See a Demo

Making a difference in healthcare

Our vision is to improve quality, diversity, and integration of information by using technology to bridge the gap between market research and clinical science across the healthcare industry.

From the CEO

I have always been interested in how to disrupt the system of basic and clinical medical research to achieve better outcomes for people afflicted with disease. For me, it started with building systems that incorporated biomarker discovery and patient selection strategies to better predict which patients would truly benefit from which therapies. The most critical part of clinical research is the end game; unfortunately, most drugs underperform once they are broadly launched into the market, resulting in less-than-optimal care.

The advent and ubiquitous nature of mobile technology now give us the opportunity to understand the patient experience. Our company was founded to seamlessly integrate clinical data with market research in real-time to quickly deliver higher-quality drugs to patients in need.

RespondHealth
Founder and CEO

See The Impact We’ve Made

Meet our team

Our team consists of leaders in science, health policy and privacy with expertise in leveraging technology to bridge the gap between healthcare expectation and real-life implementation.

VICKI SEYFERT-MARGOLIS

Founder and CEO

Linkedin
READ VICKI’S BIO

Vicki brings extensive experience and network connections in regulatory science and policy, innovative clinical trial designs, immunology and infectious disease studies, and advanced data analytics.

TOM DELAY

Chief Business Officer

Linkedin
READ TOM'S BIO

Banking professional, lawyer and entrepreneur with 25+ years of experience supporting the commercial acceleration of finance, tech and healthcare companies.

MOLLY MULDOON

Chief Administrative Officer

Linkedin
READ MOLLY’S BIO

Seasoned executive with 20+ years in healthcare including medical product regulatory, reimbursement and legislative policy as well as extensive experience in operational and administrative executive oversight for multiple organizations

PATRICK ETYNGIER

Chief Technology Officer

Linkedin
READ PATRICK’S BIO

MedTech professional and entrepreneur with 18+ years of experience in Clinical Research, Technology & Data management.

SAMMI MENTIS

Director, Operations

Linkedin
READ SAMMI'S BIO

Seasoned professional with over 20 years of experience in the clinical research space, specifically in client management, operations and logistics, and budget oversight.

 

ERIKA ALONSO

Brand Strategy and Trade Marketing

Linkedin
READ ERIKA’S BIO

Marketing executive and entrepreneur with decades of cross-platform experience delivering transformative B2B2C solutions for large market leaders, emerging disruptors and companies who aspire to be both.

CARLEEN HAWN

Advisor

Linkedin
READ CARLEEN’S BIO

Business and financial journalist-turned entrepreneur with 15+ years of experience supporting the development and commercial acceleration of transformative healthcare companies.

SRIRAMA VENKATARAMAN

Advisor

Linkedin
READ SRI’S BIO

Seasoned professional and an entrepreneur with experience in clinical research, health data sourcing and algorithm development in med-tech industry.

Facebook Twitter Linkedin

6701 Democracy Boulevard 
Suite 300, Bethesda 
MD 20817

  • 240.356.1008
  • information@respondhealth.net

©2023 RespondHealth

Vicki Seyfert-Margolis, Ph.D.

 

Dr. Seyfert-Margolis founded RespondHealth (previously known as My Own Med, Inc.) to disrupt incumbent methods of clinical trialing, new product trialing and patient registry development – all in service of her aim to deliver better health outcomes to those afflicted with disease, both in care settings and out in the real world, where patients live their best lives.

Prior to RespondHealth, Vicki served in the Obama Administration as Senior Advisor for Science Innovation and Policy in the Office of the Commissioner of the US Food and Drug Administration, where she oversaw the development and execution of an agency-wide strategic plan for regulatory science. In this capacity, Vicki worked with academic and industry leaders on myriad science, regulatory and policy initiatives, encompassing mobile technologies, innovation in drug development, and companion diagnostics. 

Previously, Vicki served as Chief Scientific Officer at the Immune Tolerance Network (ITN), a non-profit consortium of researchers seeking new treatments for diseases of the immune system, where she guided more than 20 leading-edge assay development and centralized laboratory facilities to GLP and CLIA compliance. Vicki also previously served as Director of the Office of Innovative Scientific Research Technologies at the National Institute of Allergy and Infectious Diseases within the National Institutes of Health,  where she focused on integrating emerging technologies with NIH’s existing immunology and infectious disease programs.  

 Over her career, Vicki has designed and implemented more than 35 innovative Phase II and registration clinical trials. She is the author of 31+ academic white papers and peer-reviewed research papers, and she is a frequent keynote speaker on the topics of regulatory and drug discovery trends and the transformative impacts of digital technology on healthcare.  

 Vicki completed her PhD in immunology at the University of Pennsylvania’s School of Medicine, and her post-doctoral fellowship work at Harvard University and the National Cancer Institute. Vicki serves as a Board Director for the EveryLife Foundation for Rare Diseases, and the Eureka Institute for Translational Medicine.

To learn more, see: Solutions – RespondHealth

TOM DELAY

Tom is Chief Executive Officer of Healthspottr Capital and Chief Operating Officer of Healthspottr LLC. For more than 25 years, Tom has leveraged his legal and banking background to support the growth and commercial success of innovative and established firms in the tech, financial services and healthcare industries.

Early in his career, Tom served as General Counsel and head of exotic debt (pre-Brady debt) for New Capital Markets, a DC-based hedge fund focused on privatization in Russia and Eastern Europe. He later helped launch the family office business for Wells Fargo and served as Senior Vice President at U.S. Trust, where he managed a $2.5 billion portfolio for several ultra-high net worth families in the Bay Area.

In tech, Tom held senior business development roles at startups including Bang Networks and BeNotified Software. He entered healthcare by co-founding iHealth Analytics, a comparative analytics and resource utilization platform that sought to bring the same state-of-the art operating efficiencies long-used in finance to healthcare providers and payers for the first time.

Tom joined Healthspottr as COO in 2013 and most recently launched Healthspottr Capital, which provides capital raising and M&A services to large and small firms. Tom is a senior advisor to several companies including Axenic Health Solutions, which offers a novel, long-lasting sanitizing and disinfecting solutions for retail and healthcare settings, Care Angel, an AI-based nurse assistance provider, AIMO, a German startup leveraging motion analysis and AI to detect injury, pain and anxiety, and RespondHealth.

Tom earned his B.A from University of Iowa and a J.D. from Kansas University School of Law with a focus on international law and the impact on contracting in the oil and gas industry in Russia and Eastern Europe.

Molly Muldoon

Molly Muldoon is the Chief Administrative Officer at RespondHealth. Previously she served as the Vice President of Public Policy for Onyx Pharmaceuticals. She was responsible for establishing and leading key policy and regulatory positions for the company.

Ms. Muldoon was formerly the Federal Drug Administration’s (FDA) Chief of Staff, overseeing the operations and liaising with senior leadership across the federal government on key issues including the Affordable Care Act, Deepwater Horizon, food safety regulations, and food borne outbreaks. As a seasoned leader in organizational change and strategic planning, she has served as the Chief Administrative Officer for both the National Restaurant Association and AARP Services. During her respective tenures she guided the organizations through organizational re-alignments, strategic planning efforts and assisted with identifying increased efficiency opportunities and expanding public outreach activities.

Ms. Muldoon served in the Clinton Administration for both terms at the White House and the Department for Health and Human Services (HHS). Her roles included Special Assistant to the White House Chief of Staff, Special Assistant to Counselor for the President, and finally Special Assistant to the Deputy Secretary of HHS.

Patrick Etyngier, Ph.D.

Patrick is a 15+ years experienced innovation leader, with a demonstrated history of working in the hospital & health care industry, and strong appetence for compliance (regulatory, Fair Market Value etc.). Skilled in Medical Devices, Health Data Management, Biomedical Engineering, Healthcare, and Research and Development (R&D).

Patrick is the CTO of RespondHealth, evolved from the acquisition and integration of Santé Value by MyOwnMed. As CTO of Santé Value he focused on placing the individual at the center of the health data sharing process, ensuring direct incentivization in the context of Real-World Evidence studies and Clinical trial.

Prior to that Patrick drove to the creation of research/innovation hubs for Philips, in partnership with hospitals, academic center and related eco-systems across Europe. He contributed to clinical research in various domains such as in cardiology and oncology and the use of imaging and data to better/faster diagnose related diseases.

Patrick obtained a PhD in computer science & applied math from Ecole des Ponts ParisTech and contributed to the scientific advances at the intersection of machine learning and image processing. His work was published in highly selective international conferences.

Sammi Mentis

Sammi Mentis is the Director, Operations at RespondHealth, responsible for the day-to-day operations of the Company. More recently, she also took on the client operations management role, overseeing all client activities for ongoing projects. Previously she served as the Manager, Site Support and Logistics Management at CardioCore Labs, Inc., where she was responsible for all operational activities for global provisioning of ECG and Holter equipment to clinical sites, from project start-up phase through project closing.

Prior to that Sammi worked as a Finance Analyst at the Immune Tolerance Network (UCSF) within the Tolerance Assay and Data Analysis Group, managing the group’s $11M budget and creating and managing the individual clinical trial budgets.

Sammi has a BSc. Finance/Management Studies from University of Maryland University College

ERIKA ALONSO

Erika is Co-founder and Chief Storyteller of Stairwell D, an agency specializing in digital B2B founded in 2008. Under Erika’s leadership, Stairwell D’s clients have included Discovery Communications, NBCUniversal, and Admeld (Google).

Erika also served as Chief Marketing Officer for Piccing, Inc, where she led global marketing, and user-experience. In this role, Erika repositioned Piccing into a social shopping experience resulting in 204% YOY revenue growth, 12 million monthly active users, and won the “Bully Award for European Innovation” at the 2015 White Bull Summit among +500 startups. In addition, she has led the branding and marcomm strategies for such seminal companies and brands as AOL/TimeWarner, Luminant Worldwide (now Razorfish.)

Perhaps most influential, however, is her work at Apple, Inc, where Erika developed the story for Apple’s global mobile advertising platform, known as iAd. She translated this positioning into a strategic product roadmap for Apple, thought leadership keynotes, sales collateral and creative partnerships with Fortune 50 brands.

After years envisioning and delivering strategies for others, Erika turned to entrepreneurship. In 2018 she co-founded Witi (Wellness Insight Technologies, Inc.), developer of Kazu, a hardware and software ecosystem in the rapidly growing cannabis sector. Kazu’s patented solution offers consumers a safe, personalized experience with precision dosing, and guidance from it’s integrated touch screen. The IP is currently licensed and under development by pharmaceutical company Perrigo [NYSE:PRGO]  deployed over a hand-held, medical-grade nicotine cessation therapy (NRT) device.  

An accomplished artist, Erika’s illustrations include projects with Geffen Records for MTV Music Awards, album covers for Smashing Pumpkins and her digital fine art inspired couture fashion designer Vivienne Tam who integrated Erika’s “Psychedellic Buddha” in her Spring 2000 Resort Collection. 

Erika earned her BFA in Communication Design and Illustration from Parson’s School of Design where she has served as a guest lecturer in the discipline of “Conceptual Thinking.” Erika is a native Spanish speaker, loves playing Devil’s Advocate and often starts a conversation with “Hmmmm… What if?” 

CARLEEN HAWN

Carleen is co-founder and CEO of Healthspottr LLC, a strategic networking and consulting company dedicated to accelerating the transformation of U.S. healthcare through technology and business-model innovations. Carleen has served as CEO since its inception and leads both the consulting and conferencing practices. Healthspottr Consulting, provides advisory services focused on strategy, business development, market development, product development, talent acquisition and thought leadership. Healthspottr Media curates in-person and virtual convenings to help participants foster new ideas, new relationships, and opportunities for new business with one another.

Prior to Healthspottr, Carleen spent nearly two decades as an award-winning business journalist, most notably with Forbes, where she created the well-known Midas List, an index of leading venture capital dealmakers now in its 22nd year of publication. Carleen later served as West Coast Bureau Chief for Fast Company magazine. Her work has appeared in numerous magazines including WIRED, Business 2.0 and Health Affairs.

Carleen serves as a board director or advisor to several firms, including Newtopia (NEWU), a habit change platform serving individuals at risk of chronic diseases, and My Own Med, Inc.

Carleen earned a B.A. from Barnard College, her M.S. from Columbia’s Graduate School of Journalism and attended both Columbia Law School and Columbia Business School as a Knight-Bagehot Fellow.

Srirama Venkataraman, PhD, MBA

Srirama Venkataraman, PhD, MBA, has career history of pushing the boundaries of clinically meaningful innovations to address the tenets of Quadruple Aim (improving the clinical experience, outcomes, patient experience and lowering costs of delivery).

Prior to RespondHealth, he was the CEO and co-founder of Santé Value, a direct to patients’ health data sourcing company acquired by RespondHealth. Sri has over 25 years of experience in healthcare working at venerable innovators such as Fox Chase Cancer Center, Mayo Clinic, Columbia University, Philips, Stryker & Promaxo with a focus on developing meaningful clinical solutions for patients and providers. Srirama also has rich experience in front-end R&D, strategic partnerships, cross functional team management, open innovations, algorithm development, health data governance and management. He  has developed and managed programs in breast and prostate cancer, cardiac and cardiovascular imaging, neurological and metabolic disease. Srirama is an advisor to 8Chili and Kyto Lifesciences.

Srirama holds a PhD in Physics from Michigan Technological University and MBA from Rutgers Business School.